TrialInternational journal of nanomedicine2017

Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155.

Yang Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.